In November 2024, in the first successful private cause of action under the Anti-Foreign Sanctions Law (AFSL), a Chinese court adjudicated a civil claim by a Chinese company against its overseas customer for failure to pay...more
6/5/2025
/ Breach of Contract ,
China ,
Contract Disputes ,
Dispute Resolution ,
Economic Sanctions ,
Enforcement Actions ,
International Arbitration ,
International Trade ,
Jurisdiction ,
Office of Foreign Assets Control (OFAC) ,
SDN List
Designed for busy in-house counsel, compliance professionals, and anti-corruption lawyers, this newsletter summarizes some of the most important international anti-corruption law and enforcement developments from the past...more
5/21/2025
/ Anti-Corruption ,
Bribery ,
Corporate Counsel ,
Corruption ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Executive Orders ,
Foreign Corrupt Practices Act (FCPA) ,
Serious Fraud Office (SFO) ,
State Attorneys General ,
Trump Administration
On January 10, 2025, China’s State Administration for Market Regulation (“SAMR”) put into effect its Compliance Guidelines for Healthcare Companies to Prevent Commercial Bribery Risks (“Compliance Guidelines”)....more
2/12/2025
/ Anti-Corruption ,
China ,
Clinical Laboratories ,
Compliance ,
Corporate Governance ,
Corruption ,
Enforcement Actions ,
Fraud ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Medical Research ,
Pharmaceutical Industry ,
Regulatory Agenda ,
Regulatory Requirements ,
Risk Management
On October 11, 2024, China’s State Administration for Market Regulation (“SAMR”) issued the Draft Compliance Guidelines for Healthcare Companies to Prevent Commercial Bribery Risks (“Draft Guidelines”). These guidelines...more